跳至主要内容
临床试验/NCT04900324
NCT04900324Unknown不适用

Intramuscular Injections of Botulinum Toxin in Lateral Pterygoid Muscle in the Treatment of Temporomandibular Dysfunctions: Studying the Interest of MRI Guidance and Ultrasound Guidance

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2021年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
48
试验地点
1
主要终点
Pain improvement

研究概览

简要总结

The main hypothesis is that a significant pain improve (measured with Visual Analogic Scale [VAS]) can be observed after injection of botulinum toxin A, meaning the success of the guidance device.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients suffering from muscular TemporoMandibular Dysfunctions (TMD) with clinical diagnosis: myofascial pain, limited opening of the mouth, articular noise.
  • >= 18 years old
  • with signed informed consent form

排除标准

  • articular TMD: arthritis or other inflammatory disease of temporomandibular joint, arthrosis, bone deformation, previous fracture of condylar area ;
  • electromyographic hypoactivity, pure muscular diseases ;
  • oro-mandibular dystonia ;
  • botulinum toxin allergy,
  • risk of bleeding
  • recent or active infection
  • intercurrent antibiotic treatment (drug interaction) ;
  • vaccination during the 15 days preceding the injection.

结局指标

主要结局

Pain improvement

时间窗: Month 2

Significant improvement of the pain measured with VAS (0 to 10), corresponding to at least 30% decrease of the pain after injection of botulinum toxin A

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验